This study was conducted between June @ , @ , and September @ , @ infants were enrolled and @ randomized at @ mo of age to no chemoprevention , monthly sulfadoxine-pyrimethamine ( SP ) , daily trimethoprim-sulfamethoxazole ( TS ) , or monthly dihydroartemisinin-piperaquine ( DP ) .